Company Profiles

driven by the PitchBook Platform

Abeterno

2011 FOUNDED
OOB STATUS
1-10 EMPLOYEES
Liquidation LATEST DEAL TYPE
Description

Developer of research tools for cell separation and live cell imaging. The company's research tools have developed novel cell isolation technology that makes use of magnetic nanoparticles to purify live cells using intracellular proteins.

Ownership Status
Out of Business
Financing Status
Formerly VC-Backed
Primary Industry
Biotechnology
Primary Office
Cambridge
England
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Abeterno’s full profile, request a free trial.

Abeterno Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Bankruptcy: Liquidation Completed Bankruptcy: Liquidation
1. Seed Round Completed Startup
To view this company’s complete deal history including valuation and funding request access »

Abeterno Executive Team (2)

Name Title Board
Seat
Contact
Info
Rosalind Codrington Ph.D Founder & Chief Scientific Officer
Michael McLean Ph.D Board Member & Chief Executive Officer

Abeterno Board Members (3)

Name Representing Role Since Contact
Info
Alex Griffitths Abeterno Board of Director 000 0000
Linda Cammish Ph.D Abeterno Board of Director 000 0000
Michael McLean Ph.D Self Board Member & Chief Executive Officer 000 0000